Chonluten

Cytogenes, unlike cytomaxes, are synthesized from natural amino acids, receiving as a result the copy of working part of the most active peptide area from all complex, which is contained in extract, that is, one shortened molecule. The synthesized peptides render faster effect, at initial stage starting function of restoration of internals. Physiologically active short peptides are reasonable to use at any age for delaying aging processes, maintenance of metabolic processes normal level, prevention and correction of various diseases, rehabilitation after serious illness, injuries and surgeries. Further, for continuation of positive dynamics in therapy, is recommended reception of cytomaxes.

Chonluten represents a complex of the short peptides contributing to normalization of liver and bronchial tube mucous membrane cells. 

Recommended for:

• chronic respiratory insufficiency,
• chronic cardiopulmonary insufficiency,
• after pneumonia,
• consequences of long artificial lung ventilation,
• respiratory distress syndrome,
• lung tuberculosis in a remission stage,
• thorax injuries,
• burns of the upper respiratory tracts,
• consequences of lung toxic damages, including poisonings with carbon monoxide,
• intensive sports activities,
• maintenance of respiratory system function at people of advanced and senile age.

Ingredients:

microcrystalline cellulose (bulking agent); hydroxypropyl methylcellulose (capsule shell), water, carrageenan (thickener), potassium acetate (acidity regulator); calcium salts of fatty acids (anti-caking agent); peptide complex AC-7, containing amino acids (glycine, glutamic acid, aspartic acid).

The recommended daily dose or 2 or 4 capsules contains 0,2 mg or 0,4 mg of peptide complex АC-7.

Recommendations for use:

adults by 1 or 2 capsules 2 times a day during meals. Duration of use is 1 month. The use can be repeated after 3-6 months.